FDA Adverse Event Injury Summary report: N

RECOVERY G2 FILTER SYSTEM - JUGULAR DELIVERY KIT

MDR report key: 1642301 · Received March 23, 2010

Report

Report Number
2020394-2010-00104
Event Type
Injury
Date Received
March 23, 2010
Date of Event
February 16, 2010
Report Date
February 24, 2010
Manufacturer
BARD PERIPHERAL VASCULAR, INC.
Product Code
DTK
PMA / PMN Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS WERE REVIEWED WITH SPECIAL ATTENTION TO THE RAW MATERIALS, THE SUBASSEMBLIES, THE MFG PROCESS AND THE QC TESTING. THIS LOT MET ALL RELEASE CRITERIA. THERE WAS NOTHING FOUND IN THE RECORDS TO INDICATE THERE WAS A MFG RELATED CAUSE FOR THIS EVENT. THIS IS THE ONLY COMPLAINT REPORTED TO DATE FOR THIS LOT NUMBER. THE FILTER HAS BEEN RETURNED FOR EVAL. THE INVESTIGATION IS CURRENTLY UNDERWAY. THIS EVENT IS BEING REPORTED BECAUSE THIS DEVICE IS THE SAME OR SIMILAR TO ONE MARKETED IN THE UNITED STATES 510(K): K052578.

Description of Event or Problem · 1

IT WAS REPORTED THAT 5 DAYS AFTER FILTER IMPLANT, IT WAS IDENTIFIED THAT THE FILTER MIGRATED CAUDALLY AND WAS TILTED 90 DEGREES. THE FILTER WAS SUCCESSFULLY PLACED USING THE JUGULAR APPROACH. FIVE DAYS LATER, PRIOR TO A SCHEDULED RETRIEVAL, "PHLEBOGRAPHY" AND CT EXAM SHOWED MALPOSITION OF THE FILTER. IT WAS IDENTIFIED THAT THE FILTER HAD MIGRATED CAUDALLY, AND BECAME CAUGHT IN THE RENAL VEINS. THIS CAUSED THE FILTER TO TILT APPROX 90 DEGREES. THE ATTEMPTED RETRIEVAL WAS CANCELLED. HOWEVER, A SUBSEQUENT PROCEDURE WAS PERFORMED. THE APPROACH WAS VIA THE FEMORAL VEIN UTILIZING A LONG SHEATH. REPORTEDLY, THE PHYSICIANS WERE NOT ABLE TO COMPLETELY RETRACT THE FILTER INTO THE SHEATH. A CUTDOWN WAS PERFORMED AND THE FILTER WAS SUCCESSFULLY WITHDRAWN THROUGH THE FEMORAL VEIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RECOVERY G2 FILTER SYSTEM - JUGULAR DELIVERY KIT DTK BARD PERIPHERAL VASCULAR, INC. GFRG4886

Patients

Seq Age Sex Outcome Treatment
1 18 YR Required Intervention